Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. March 2022, section EUDA news
23. April 2026 Coming soon: European Drug Report 2026 to be released on 9 June in Brussels New substances, new markets, new risks — understanding Europe’s changing drug landscape starts with solid facts. On 9 June,...
